CADM4 c.64+2864A>G

Variant ID: 19-44141015-T-C

NM_145296.1(CADM4):c.64+2864A>G

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Clinical, genetic, and experimental increase in soluble urokinase plasminogen activator receptor levels promotes atherosclerosis.

The Journal Of Clinical Investigation
Hindy, George G; Tyrrell, Daniel J DJ; Vasbinder, Alexi A; Wei, Changli C; Presswalla, Feriel F; Wang, Hui H; Blakely, Pennelope K PK; Ozel, Ayse Bilge AB; Graham, Sarah E SE; Holton, Grace H GH; Dowsett, Joseph J; Fahed, Akl C AC; Amadi, Kingsley-Michael KM; Erne, Grace K GK; Tekumulla, Annika A; Ismail, Anis A; Launius, Christopher C; Sotoodehnia, Nona N; Pankow, James S JS; Thørner, Lise Wegner LW; Erikstrup, Christian C; Pedersen, Ole Birger OB; Banasik, Karina K; Brunak, Søren S; Ullum, Henrik H; Eugen-Olsen, Jesper J; Ostrowski, Sisse Rye SR; Haas, Mary E ME; Nielsen, Jonas B JB; Lotta, Luca A LA; Engström, Gunnar G; Melander, Olle O; Orho-Melander, Marju M; Zhao, Lili L; Murthy, Venkatesh L VL; Pinsky, David J DJ; Willer, Cristen J CJ; Heckbert, Susan R SR; Reiser, Jochen J; Goldstein, Daniel R DR; Desch, Karl C KC; Hayek, Salim S SS
Publication Date: 2022-10-04

Variant appearance in text: rs400058
PubMed Link: 36194491
Variant Present in the following documents:
  • jci-132-158788-s008.pdf
  • jci-132-158788.pdf
View BVdb publication page